5,274 iShares Biotechnology ETF $IBB Shares Sold by FSA Wealth Partners Inc.

FSA Wealth Partners Inc. lessened its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 52.5% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,778 shares of the financial services provider’s stock after selling 5,274 shares during the quarter. FSA Wealth Partners Inc.’s holdings in iShares Biotechnology ETF were worth $1,006,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of IBB. Bank of America Corp DE lifted its stake in shares of iShares Biotechnology ETF by 10.8% during the 1st quarter. Bank of America Corp DE now owns 7,259,501 shares of the financial services provider’s stock valued at $1,225,767,000 after buying an additional 707,343 shares in the last quarter. Royal Bank of Canada boosted its holdings in iShares Biotechnology ETF by 1.0% in the 1st quarter. Royal Bank of Canada now owns 737,128 shares of the financial services provider’s stock worth $124,464,000 after buying an additional 7,434 shares during the period. Albion Financial Group UT grew its stake in iShares Biotechnology ETF by 1.0% in the 3rd quarter. Albion Financial Group UT now owns 120,782 shares of the financial services provider’s stock valued at $25,428,000 after buying an additional 1,147 shares in the last quarter. Cetera Investment Advisers grew its stake in iShares Biotechnology ETF by 9.4% in the 1st quarter. Cetera Investment Advisers now owns 128,530 shares of the financial services provider’s stock valued at $21,702,000 after buying an additional 10,994 shares in the last quarter. Finally, Henshaw Capital LLC bought a new stake in iShares Biotechnology ETF during the 1st quarter valued at $20,262,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB stock opened at $208.69 on Tuesday. The company’s fifty day simple moving average is $207.81 and its two-hundred day simple moving average is $183.96. iShares Biotechnology ETF has a 1 year low of $154.62 and a 1 year high of $217.12.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Tuesday, September 15th were given a $0.0112 dividend. This represents a $0.04 annualized dividend and a dividend yield of 0.0%. This is a drop from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. The ex-dividend date was Tuesday, September 15th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.